Target selection for miR-100 was more challenging as there are far less validated targets and even less related to cancer progression, thus we analyzed the validated survival related target mammalian target of rapamycin (mTOR) [80,81], as well as Ago1 and Ago2 which are predicted targets of miR-100. The gene discussed is AGO1; the disease is cancer.